Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 30, 2015 16:01 ET | Source: Medgenics, Inc.

Medgenics Announces Public Offering of Common Stock

PHILADELPHIA, Sept. 30, 2015 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE MKT:MDGN) today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. The...
September 09, 2015 08:30 ET | Source: Medgenics, Inc.

Medgenics Acquires Phase 2-Ready CNS Program: NFC-1

Strong Efficacy Signal Established in Genetically Identified Subset of ADHD Patients Development will Include Neuropsychiatric Symptoms of 22q11.2 Deletion Syndrome PHILADELPHIA, Sept. 9,...
September 03, 2015 08:00 ET | Source: Medgenics, Inc.

Medgenics to Present at 22nd Annual NewsMakers in the Biotech Industry Conference

PHILADELPHIA, Sept. 3, 2015 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE:MDGN), the developer of a proprietary platform for the sustained production and delivery of therapeutic proteins and peptides in...
August 10, 2015 08:00 ET | Source: Medgenics, Inc.

Medgenics Reports Second Quarter 2015 Financial Results

Initiated enrollment in peritoneal dialysis study in U.S. Awarded $3.4 million grant from the Israeli Office of the Chief Scientist Advanced collaboration activities with...
July 15, 2015 08:00 ET | Source: Medgenics, Inc.

Medgenics Announces First Patient Enrolled in U.S.-Based Phase 2 Clinical Trial of TARGT-EPO for Treatment of Anemia in ESRD Patients Undergoing Peritoneal Dialysis

PHILADELPHIA, July 15, 2015 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE:MDGN), the developer of a proprietary platform for the sustained production and delivery of therapeutic proteins and peptides in...
June 29, 2015 08:00 ET | Source: Medgenics, Inc.

Medgenics Added to RUSSELL 3000(R) and Global Indexes

PHILADELPHIA, June 29, 2015 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE MKT:MDGN), the developer of a proprietary platform for the sustained production and delivery of therapeutic proteins and peptides...
June 17, 2015 16:01 ET | Source: Medgenics, Inc.

Medgenics to Present at JMP Securities Life Sciences Conference 2015

PHILADELPHIA, June 17, 2015 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE MKT:MDGN), the developer of a proprietary platform for the sustained production and delivery of therapeutic proteins and peptides...
June 11, 2015 08:30 ET | Source: Medgenics, Inc.

Medgenics Awarded $3.4 Million Grant From the Israeli Office of the Chief Scientist

PHILADELPHIA, June 11, 2015 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE MKT:MDGN), the developer of a proprietary platform for the sustained production and delivery of therapeutic proteins and peptides...
June 10, 2015 08:30 ET | Source: Medgenics, Inc.

Medgenics Announces Appointment of Barbara Duncan to Board of Directors

PHILADELPHIA, June 10, 2015 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE MKT:MDGN), the developer of a proprietary platform for the sustained production and delivery of therapeutic proteins and peptides...
June 04, 2015 08:30 ET | Source: Medgenics, Inc.

Medgenics to Present Clinical Data at the 20th Congress of the European Hematology Association

- New Data Presented from Ongoing Phase 1/2 Study of TARGTEPOTM PHILADELPHIA, June 4, 2015 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE MKT:MDGN), the developer of a proprietary platform for the...